Vibostolimab (anti-TIGIT) | Immunology & Inflammation related

Vibostolimab (anti-TIGIT, MK-7684) is a humanized monoclonal antibody that binds to the T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT), blocking the interaction between TIGIT and its ligands, CD112 and CD155, thereby activating T lymphocytes which help to destroy tumor cells.

Click to purchase the isotype control of Vibostolimab (anti-TIGIT)

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 4.91mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description	Vibostolimab (anti-TIGIT, MK-7684) is a humanized monoclonal antibody that binds to the T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT), blocking the interaction between TIGIT and its ligands, CD112 and CD155, thereby activating T lymphocytes which help to destroy tumor cells.

References
[1] J Niu, et al. Ann Oncol . 2021 Nov 17;S0923-7534(21)04776-1.

References

[1] J Niu, et al. Ann Oncol . 2021 Nov 17;S0923-7534(21)04776-1.

Product Details

CAS No.	2231305-30-7
Molecular Weight	145 kD
Isotype	Human IgG1, κ
Source	CHO cells
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field